Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed Eslam

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
Annals of Hepatology|June 11, 2024
MAFLD or MASLD: Let the evidence decide againZiyan Pan, Mohammed Eslam
Journal of Hepatology|March 31, 2024
The MASLD criteria overlook a number of adolescent patients with severe steatosisZiyan Pan, Mohammed Eslam,
Expert Opinion on Therapeutic Targets|September 30, 2016
Targeting IFN-λ: therapeutic implicationsMohammed Eslam, Jacob George
Hepatology International|June 17, 2024
MAFLD: from a disease framework to patient careMohammed Eslam, Jacob George
DNA and Cell Biology|May 31, 2024
MERTK and Fibrosis: A New Target for TherapyZiyan Pan, Mohammed Eslam
Nature Reviews. Gastroenterology & Hepatology|October 24, 2019
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biologyMohammed Eslam, Jacob George
Annals of Hepatology|March 28, 2025
Metabolic dysfunction and kidney disease risk in individuals with MAFLDZiyan Pan, Mohammed Eslam
Hepatology International|December 20, 2015
Genetic and epigenetic mechanisms of NASHMohammed Eslam, Jacob George
Journal of Clinical and Translational Hepatology|March 2, 2022
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An UpdateJawaher Alharthi, Mohammed Eslam
Hepatology International|October 6, 2019
Refining the role of epicardial adipose tissue in non-alcoholic fatty liver diseaseMohammed Eslam, Jacob George
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
Annals of Hepatology|June 11, 2024
MAFLD or MASLD: Let the evidence decide againZiyan Pan, Mohammed Eslam
Journal of Hepatology|March 31, 2024
The MASLD criteria overlook a number of adolescent patients with severe steatosisZiyan Pan, Mohammed Eslam,
Expert Opinion on Therapeutic Targets|September 30, 2016
Targeting IFN-λ: therapeutic implicationsMohammed Eslam, Jacob George
Hepatology International|June 17, 2024
MAFLD: from a disease framework to patient careMohammed Eslam, Jacob George
DNA and Cell Biology|May 31, 2024
MERTK and Fibrosis: A New Target for TherapyZiyan Pan, Mohammed Eslam
Nature Reviews. Gastroenterology & Hepatology|October 24, 2019
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biologyMohammed Eslam, Jacob George
Annals of Hepatology|March 28, 2025
Metabolic dysfunction and kidney disease risk in individuals with MAFLDZiyan Pan, Mohammed Eslam
Hepatology International|December 20, 2015
Genetic and epigenetic mechanisms of NASHMohammed Eslam, Jacob George
Journal of Clinical and Translational Hepatology|March 2, 2022
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An UpdateJawaher Alharthi, Mohammed Eslam
Hepatology International|October 6, 2019
Refining the role of epicardial adipose tissue in non-alcoholic fatty liver diseaseMohammed Eslam, Jacob George
Pageof 23